 |
市場調查報告書
商品編碼
1897839
造影劑市場規模、佔有率和成長分析（按類型、影像方式、給藥途徑、應用、最終用戶和地區分類）－2026-2033年產業預測Contrast Agents Market Size, Share, and Growth Analysis, By Type (Iodinated Contrast Agents, Gadolinium-Based Contrast Agents), By Imaging Modality, By Route of Administration, By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
預計到 2024 年，造影劑市場規模將達到 55.6 億美元，到 2025 年將達到 57.3 億美元，到 2033 年將達到 72.6 億美元，預測期（2026-2033 年）的複合年成長率為 3%。
複雜合併症和慢性疾病的增加顯著提高了對先進診斷影像技術的需求，包括超音波、X光、磁振造影（MRI）和電腦電腦斷層掃描）。特別是造影劑的最新進展至關重要，因為它們在提高影像準確性的同時，也優先考慮了病患安全。例如，採用低劑量钆的高對比MRI造影劑等創新技術，解決了患者暴露的重大問題。這些進展不僅有助於提高診斷影像的準確性，還能滿足從成人到兒童不同患者群體的安全需求。隨著醫療保健的發展，使用先進造影劑的診斷影像技術的改進有望在滿足日益成長的有效診斷解決方案需求方面發揮關鍵作用。
對比造影市場促進因素
影像導引手術的日益普及標誌著醫學領域的變革性轉變。這些創新技術能夠診斷和治療多種疾病，正逐漸受到醫學專業人士的青睞。手術過程中對精準即時影像的需求日益成長，催生了對資料收集、處理和視覺化等先進調查方法的需求。這一發展也凸顯了深入理解成像技術及其治療意義的重要性，進而推動了對高效造影劑的需求，以提高影像質量，並支持在各種臨床情況下成功進行手術治療。
造影市場限制
儘管醫療技術的進步和造影劑的研發提高了診斷影像的效率，但部分患者仍會因使用這些物質而出現副作用和過敏反應。雖然這些不良反應並不常見，但其嚴重程度卻不一，從輕微不適到需要緊急醫療介入的嚴重健康問題都有可能。常見的症狀包括皮膚刺激、噁心和呼吸困難，在極少數情況下，甚至可能導致危及生命的過敏性休克。由於患者的安全和舒適在醫學影像檢查中至關重要，因此，這項持續存在的挑戰對造影劑市場構成了重大阻礙因素。
造影市場趨勢
受人口老化和多種慢性疾病（尤其是65歲及以上）盛行率上升的推動，造影劑市場呈現強勁成長趨勢。不斷變化的醫療環境促使人們對利用造影劑的先進診斷影像技術的需求激增，以便更好地管理該年齡層的複雜合併症。這種需求成長源自於越來越多的患者需要對包括心血管疾病和癌症在內的各種疾病進行精準診斷和治療後續觀察。因此，造影劑配方和造影技術的創新發展有望改善患者預後並進一步擴大市場。
目錄
介紹
- 調查目標
- 調查範圍
- 定義
調查方法
- 資訊收集
- 二手資料和一手資料方法
- 市場規模預測
- 市場假設與限制
執行摘要
- 全球市場展望
- 供需趨勢分析
- 細分市場機會分析
市場動態與展望
- 市場規模
- 市場動態
- 促進因素和機遇
- 限制與挑戰
- 波特分析
關鍵市場考察
- 關鍵成功因素
- 競爭程度
- 關鍵投資機會
- 市場生態系統
- 市場吸引力指數（2025）
- PESTEL 分析
- 總體經濟指標
- 價值鏈分析
- 定價分析
全球造影劑市場規模（按類型和複合年成長率分類）（2026-2033 年）
- 碘造影劑
- 钆基造影劑
- 鋇基造影劑
- 微氣泡造影劑
- 其他
全球造影劑市場規模（以影像方式分類）及複合年成長率（2026-2033 年）
- X光/CT
- MRI
- 超音波
- 其他
全球造影劑市場規模（依給藥途徑及複合年成長率分類）（2026-2033 年）
- 血管內給藥
- 口服/直腸給藥
- 其他
全球造影劑市場規模（按應用及複合年成長率分類）（2026-2033 年）
- 循環系統
- 神經系統疾病
- 癌症
- 消化系統疾病
- 肌肉骨骼疾病
- 其他
全球造影劑市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）
- 醫院
- 診斷影像中心
- 門診手術中心
- 其他
全球造影劑市場規模及複合年成長率（2026-2033）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區
競爭資訊
- 前五大公司對比
- 主要企業的市場定位（2025 年）
- 主要市場參與者所採取的策略
- 近期市場趨勢
- 公司市佔率分析（2025 年）
- 主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- Bayer AG（Germany）
- Bracco Imaging SpA（Italy）
- GE Healthcare（US）
- Guerbet（France）
- Lantheus Medical Imaging, Inc.（US）
- NanoPET Pharma GmbH（Germany）
- Fujifilm Corporation（Japan）
- Beijing Beilu Pharmaceutical Co. Ltd.（China）
- Taejoon Pharm Co. Ltd.（South Korea）
- Jubilant Life Sciences Ltd.（India）
- Siemens Healthineers（Germany）
- Philips Healthcare（Netherlands）
- Cardinal Health（US）
- McDermott International（US）
- Medtronic（Ireland）
- Terumo Corporation（Japan）
- Abbott Laboratories（US）
- Baxter International（US）
- Fresenius Medical Care AG & Co. KGaA（Germany）
- Novartis AG（Switzerland）
結論與建議
Contrast Agents Market size was valued at USD 5.56 Billion in 2024 and is poised to grow from USD 5.73 Billion in 2025 to USD 7.26 Billion by 2033, growing at a CAGR of 3% during the forecast period (2026-2033).
The increasing prevalence of complex comorbidities and chronic illnesses has led to a notable rise in the demand for diagnostic imaging procedures, including ultrasound, X-rays, and advanced methods like MRI and CT scans. Recent advancements in contrast agents, specifically those that enhance imaging precision while prioritizing patient safety, have become essential. Innovations such as high-relativity MRI contrast agents with reduced gadolinium dosages are addressing critical concerns regarding patient exposure to this element. These developments not only improve imaging accuracy but also cater to the safety needs of diverse patient populations, including both adults and children. As healthcare continues to evolve, the enhancement of diagnostic imaging techniques through advanced contrast agents is set to play a vital role in meeting the growing demand for effective diagnostic solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Contrast Agents Market Segments Analysis
Global Contrast Agents Market is segmented by Type, Imaging Modality, Route of Administration, Application, End User and region. Based on Type, the market is segmented into Iodinated Contrast Agents, Gadolinium-Based Contrast Agents, Barium-Based Contrast Agents, Microbubble Contrast Agents and Others. Based on Imaging Modality, the market is segmented into X-Ray/CT, MRI, Ultrasound and Others. Based on Route of Administration, the market is segmented into Intravascular, Oral/Rectal and Others. Based on Application, the market is segmented into Cardiovascular, Neurological Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders and Others. Based on End User, the market is segmented into Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Contrast Agents Market
The growing acceptance of image-guided surgeries signifies a transformative shift in the medical field. These innovative procedures, which facilitate both diagnosis and treatment of diverse medical conditions, are gaining traction among healthcare professionals. As the need for accurate, real-time imaging during surgical interventions intensifies, there arises a demand for advanced methodologies in data acquisition, processing, and visualization. This evolution also underscores the importance of a thorough grasp of imaging techniques and their therapeutic implications, thereby driving the necessity for effective contrast agents that enhance imaging quality and support successful surgical outcomes in a variety of clinical scenarios.
Restraints in the Contrast Agents Market
Although advancements in medical technology and the development of contrast agents have improved imaging procedures, there remains a portion of patients who experience side effects or allergic reactions to these substances. While such adverse reactions are infrequent, they can vary in severity, from mild discomfort to serious health concerns that require urgent medical intervention. Common symptoms associated with these reactions include skin irritations, nausea, and difficulty breathing, with rare instances leading to life-threatening conditions like anaphylaxis. This ongoing issue poses a significant restraint in the contrast agents market, as patient safety and comfort remain paramount in medical imaging practices.
Market Trends of the Contrast Agents Market
The Contrast Agents market is witnessing a robust growth trend driven by the increasing prevalence of multiple chronic conditions among the aging population, particularly adults aged 65 and older. As the healthcare landscape evolves, the demand for advanced diagnostic imaging techniques, which utilize contrast agents, is surging to better manage complex comorbidities in this demographic. This growing need is fueled by the rising number of patients requiring accurate diagnoses and treatment monitoring for various conditions, including cardiovascular diseases and cancers. Consequently, innovative developments in contrast agent formulations and improved imaging technologies are anticipated to enhance patient outcomes, further propelling market expansion.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Contrast Agents Market Size by Type & CAGR (2026-2033)
- Market Overview
- Iodinated Contrast Agents
- Gadolinium-Based Contrast Agents
- Barium-Based Contrast Agents
- Microbubble Contrast Agents
- Others
Global Contrast Agents Market Size by Imaging Modality & CAGR (2026-2033)
- Market Overview
- X-Ray/CT
- MRI
- Ultrasound
- Others
Global Contrast Agents Market Size by Route of Administration & CAGR (2026-2033)
- Market Overview
- Intravascular
- Oral/Rectal
- Others
Global Contrast Agents Market Size by Application & CAGR (2026-2033)
- Market Overview
- Cardiovascular
- Neurological Disorders
- Cancer
- Gastrointestinal Disorders
- Musculoskeletal Disorders
- Others
Global Contrast Agents Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Others
Global Contrast Agents Market Size & CAGR (2026-2033)
- North America (Type, Imaging Modality, Route of Administration, Application, End User)
- US
- Canada
- Europe (Type, Imaging Modality, Route of Administration, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Imaging Modality, Route of Administration, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Imaging Modality, Route of Administration, Application, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Imaging Modality, Route of Administration, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bracco Imaging SpA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Guerbet (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lantheus Medical Imaging, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NanoPET Pharma GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beijing Beilu Pharmaceutical Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Taejoon Pharm Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jubilant Life Sciences Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- McDermott International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
2025年全球造影治療設備市場報告
造影劑市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、檢查方式（X光/電腦斷層掃描、磁振造影和超音波）、適應症、地區和競爭格局分類，2020-2030年預測
周邊血管血管造影術劑市場規模、佔有率和趨勢分析報告：按模式、產品、最終用途、地區和細分市場預測（2025-2033 年）2025年全球造影劑注射線市場報告
MRI造影劑市場按產品類型、藥物類別、應用、最終用途、分銷管道和給藥途徑分類－2025-2032年全球預測造影劑市場依造影類型、給藥方式、應用、最終用戶和分銷管道分類－2025-2032年全球預測顯影劑市場按產品類型、影像方式、劑型、給藥途徑、應用和最終用戶分類－全球預測 2025-20322025年MRI顯影劑全球市場報告2025年全球顯影劑治療設備市場報告
Gadoquatrane的全球市場